| scholarly article | Q13442814 |
| P50 | author | Herbert W. Virgin | Q28407524 |
| Samuel H Speck | Q94468728 | ||
| P2093 | author name string | Joy Loh | |
| Sharookh B Kapadia | |||
| Scott A Tibbetts | |||
| Meagan A Jacoby | |||
| James S McClellan | |||
| Victor Van Berkel | |||
| P2860 | cites work | The probability of in vivo reactivation of herpes simplex virus type 1 increases with the number of latently infected neurons in the ganglia | Q24523533 |
| Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant | Q33782029 | ||
| Disruption of the murine gammaherpesvirus 68 M1 open reading frame leads to enhanced reactivation from latency | Q33798023 | ||
| Optimized viral dose and transient immunosuppression enable herpes simplex virus ICP0-null mutants To establish wild-type levels of latency in vivo | Q33806643 | ||
| T-cell vaccination alters the course of murine herpesvirus 68 infection and the establishment of viral latency in mice. | Q33824612 | ||
| Disruption of the M2 gene of murine gammaherpesvirus 68 alters splenic latency following intranasal, but not intraperitoneal, inoculation | Q34331333 | ||
| A gamma-herpesvirus sneaks through a CD8(+) T cell response primed to a lytic-phase epitope | Q35601591 | ||
| Comprehensive quantification of herpes simplex virus latency at the single-cell level | Q35888505 | ||
| CD4(+) T cell-mediated control of a gamma-herpesvirus in B cell-deficient mice is mediated by IFN-gamma | Q36338436 | ||
| Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells | Q36367286 | ||
| Identification of the in vivo role of a viral bcl-2 | Q36370194 | ||
| The function of herpes simplex virus genes: a primer for genetic engineering of novel vectors | Q37247688 | ||
| Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells | Q39550075 | ||
| The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. | Q39592670 | ||
| B cells regulate murine gammaherpesvirus 68 latency | Q39593978 | ||
| Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus | Q39684093 | ||
| Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice | Q39685855 | ||
| Effective vaccination against long-term gammaherpesvirus latency | Q39700306 | ||
| Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. | Q39876421 | ||
| Murine gamma-herpesvirus 68 glycoprotein 150 protects against virus-induced mononucleosis: a model system for gamma-herpesvirus vaccination | Q40973799 | ||
| Is EBV persistence in vivo a model for B cell homeostasis? | Q41180281 | ||
| The conditions of primary infection define the load of latent viral genome in organs and the risk of recurrent cytomegalovirus disease. | Q41946457 | ||
| Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients | Q42149577 | ||
| Immunological control of a murine gammaherpesvirus independent of CD8+ T cells | Q56798222 | ||
| The wood mouse is a natural host for Murid herpesvirus 4 | Q57209477 | ||
| Virological and pathological features of mice infected with murine gamma-herpesvirus 68 | Q67504691 | ||
| Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo | Q67970625 | ||
| Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells | Q71071715 | ||
| Isolation of five strains of herpesviruses from two species of free living small rodents | Q72461119 | ||
| Antibody-mediated control of persistent gamma-herpesvirus infection | Q77892612 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7696-7701 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Establishment and maintenance of gammaherpesvirus latency are independent of infective dose and route of infection | |
| P478 | volume | 77 |
| Q40263261 | A gamma-herpesvirus deficient in replication establishes chronic infection in vivo and is impervious to restriction by adaptive immune cells |
| Q34302056 | A gammaherpesvirus 68 gene 50 null mutant establishes long-term latency in the lung but fails to vaccinate against a wild-type virus challenge. |
| Q34082662 | A gammaherpesvirus cooperates with interferon-alpha/beta-induced IRF2 to halt viral replication, control reactivation, and minimize host lethality. |
| Q39808338 | A gammaherpesvirus ubiquitin-specific protease is involved in the establishment of murine gammaherpesvirus 68 infection |
| Q42407089 | A replication-defective gammaherpesvirus efficiently establishes long-term latency in macrophages but not in B cells in vivo |
| Q33375032 | A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus |
| Q27319763 | A virtual look at Epstein-Barr virus infection: biological interpretations |
| Q39611979 | Alpha/beta interferons regulate murine gammaherpesvirus latent gene expression and reactivation from latency |
| Q40909600 | An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection |
| Q33247469 | Antibody-independent control of gamma-herpesvirus latency via B cell induction of anti-viral T cell responses |
| Q36466487 | Autophagy Genes Enhance Murine Gammaherpesvirus 68 Reactivation from Latency by Preventing Virus-Induced Systemic Inflammation |
| Q81860691 | CD4 T cell control of acute and latent murine gammaherpesvirus infection requires IFNgamma |
| Q54667205 | Conserved gammaherpesvirus kinase and histone variant H2AX facilitate gammaherpesvirus latency in vivo. |
| Q40909739 | Critical role of CD4 T cells in an antibody-independent mechanism of vaccination against gammaherpesvirus latency |
| Q34755942 | Early establishment of gamma-herpesvirus latency: implications for immune control |
| Q33245067 | Effective control of chronic gamma-herpesvirus infection by unconventional MHC Class Ia-independent CD8 T cells |
| Q33834753 | Establishment and maintenance of long-term murine gammaherpesvirus 68 latency in B cells in the absence of CD40. |
| Q35185875 | Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin |
| Q33724273 | Ex vivo stimulation of B cells latently infected with gammaherpesvirus 68 triggers reactivation from latency |
| Q47551024 | First detection of murine herpesvirus 68 in adult Ixodes ricinus ticks |
| Q36960680 | Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis |
| Q37252878 | Glycoprotein B cleavage is important for murid herpesvirus 4 to infect myeloid cells |
| Q42412057 | Herpesvirus latency and symbiotic protection from bacterial infection |
| Q41781826 | Identification and sequencing of a novel rodent gammaherpesvirus that establishes acute and latent infection in laboratory mice |
| Q39754873 | Identification of cis sequences required for lytic DNA replication and packaging of murine gammaherpesvirus 68. |
| Q33334787 | Identification of closely spaced but distinct transcription initiation sites for the murine gammaherpesvirus 68 latency-associated M2 gene |
| Q41232435 | Immature and Transitional B Cells Are Latency Reservoirs for a Gammaherpesvirus |
| Q37302488 | Immune defence, parasite evasion strategies and their relevance for 'macroscopic phenomena' such as virulence |
| Q36232751 | Immune regulation of viral infection and vice versa |
| Q35685590 | Importance of antibody in virus infection and vaccine-mediated protection by a latency-deficient recombinant murine γ-herpesvirus-68 |
| Q33910580 | In vivo imaging of murid herpesvirus-4 infection |
| Q33270518 | Inhibition of NF-kappaB activation in vivo impairs establishment of gammaherpesvirus latency |
| Q28659593 | Latent gammaherpesvirus 68 infection induces distinct transcriptional changes in different organs |
| Q40907108 | Latent herpesvirus infection arms NK cells |
| Q52678302 | LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens. |
| Q39560812 | MHV-68 producing mIFNα1 is severely attenuated in vivo and effectively protects mice against challenge with wt MHV-68. |
| Q58701708 | Mouse Gamma Herpesvirus MHV-68 Induces Severe Gastrointestinal (GI) Dilatation in Interferon Gamma Receptor-Deficient Mice (IFNγR) That Is Blocked by Interleukin-10 |
| Q56798206 | Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load |
| Q35967300 | Multiple Lytic Origins of Replication Are Required for Optimal Gammaherpesvirus Fitness In Vitro and In Vivo |
| Q27348688 | Murid herpesvirus-4 exploits dendritic cells to infect B cells |
| Q36736774 | Murine Gammaherpesvirus 68 LANA and SOX Homologs Counteract ATM-Driven p53 Activity during Lytic Viral Replication |
| Q28474967 | Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication |
| Q33966678 | Murine gammaherpesvirus 68 LANA is essential for virus reactivation from splenocytes but not long-term carriage of viral genome |
| Q34142912 | Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB beta2 microglobulin-deficient mice |
| Q36202912 | Murine gammaherpesvirus-68 expands, but does not activate, CD11b+ gr-1+ splenocytes in vivo |
| Q34426495 | Myeloid infection links epithelial and B cell tropisms of Murid Herpesvirus-4. |
| Q92539047 | ORF6 and ORF61 Expressing MVA Vaccines Impair Early but Not Late Latency in Murine Gammaherpesvirus MHV-68 Infection |
| Q33484744 | Perturbation of lytic and latent gammaherpesvirus infection in the absence of the inhibitory receptor CEACAM1 |
| Q37254293 | Promyelocytic leukemia protein modulates establishment and maintenance of latent gammaherpesvirus infection in peritoneal cells |
| Q34602206 | Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence |
| Q35673143 | Recombinant Murine Gamma Herpesvirus 68 Carrying KSHV G Protein-Coupled Receptor Induces Angiogenic Lesions in Mice |
| Q35195727 | Rhadinovirus host entry by co-operative infection |
| Q33908762 | Role of B-cell proliferation in the establishment of gammaherpesvirus latency |
| Q43203738 | Signaling through Toll-like receptors induces murine gammaherpesvirus 68 reactivation in vivo |
| Q36798322 | Sleep and fatigue in mice infected with murine gammaherpesvirus 68. |
| Q37237637 | Suppression of TLR9 immunostimulatory motifs in the genome of a gammaherpesvirus |
| Q36835091 | Targeting the nuclear antigen 1 of Epstein-Barr virus to the human endocytic receptor DEC-205 stimulates protective T-cell responses. |
| Q36994605 | The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens |
| Q81265129 | The M4 gene of gammaHV68 encodes a secreted glycoprotein and is required for the efficient establishment of splenic latency |
| Q33355983 | The Murid Herpesvirus-4 gL regulates an entry-associated conformation change in gH. |
| Q36667866 | The absence of M1 leads to increased establishment of murine gammaherpesvirus 68 latency in IgD-negative B cells |
| Q36604481 | The limits of protection by "memory" T cells in Ig-/- mice persistently infected with a gamma-herpesvirus |
| Q33782281 | The murine gammaherpesvirus 68 M2 gene is required for efficient reactivation from latently infected B cells |
| Q45928044 | Tick-Borne Transmission of Murine Gammaherpesvirus 68. |
| Q34978471 | Type I interferons link viral infection to enhanced epithelial turnover and repair. |
Search more.